The Food and Drug Administration has granted Pfizer priority review for its new RSV vaccine designed to protect infants during their most vulnerable first six months of life.
and hospitals pushed to capacity, good news is on the horizon. The first RSV vaccine for expectant moms may be available to parents as early as August 2023.that its new RSV Vaccine for expectant moms had received priority review from the Food and Drug Administration . Instead of the typical 10 months, the FDA will aim to review the vaccine in six months with an expected action date of August 2023.
Pfizer first submitted its vaccine to the FDA for approval late last year. As a part of their submission, the vaccine manufacturerThe data from the trials found the new RSV vaccine was nearly 82 percent effective at preventing severe cases of RSV in babies’ most vulnerable first 90 days of life, and 69.4 percent effective at preventing severe cases in the first six months of life.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Mile High Asian Food Week and More Food and Drink Events This WeekGet deals at places like Meta Asian Kitchen and Bop & Gogi, plus more tasty happenings in the city that should be on your calendar.
Read more »
How Denver’s hottest food truck is shining a spotlight on the local AAPI food scenePenelope Wong was prepared for an angry mob. It was Yuan Wonton’s first day of service, and her food truck was parked outside Seedstock Brewery on a hot August afternoon in 2019.
Read more »
No cow needed: Oat and soy can be called milk, FDA proposesFood and Drug Administration officials issued guidance that says plant-based beverages don’t pretend to be from dairy animals — and that U.S. consumers aren’t confused by the difference.
Read more »
FDA agrees to review Pfizer's RSV vaccine for pregnant individualsThe Food and Drug Administration has accepted an application from Pfizer to review its RSV vaccine for pregnant individuals.
Read more »
First-ever RSV vaccine could be approved, roll out by AugustIf approved, it would be the first vaccine given to expectant mothers to protect against the disease, currently the leading cause of hospitalizations for infants.
Read more »
RSV vaccines to receive review by FDA advisory panelA vaccine advisory committee for the Food and Drug Administration will review whether to recommend two vaccines for respiratory syncytial virus for approval next week as pharmaceutical giant Pfizer and rival drug manufacturer GSK vie to have the first RSV vaccine to hit the U.S. market.
Read more »